Rob Boyce is the CEO of Plakous Therapeutics, a biotech startup in Winston-Salem, NC, that is developing a therapy to prevent a rare pediatric disease, necrotizing enterocolitis. Rob has been working in healthcare and life sciences throughout his career. He has been part of several startup companies in diagnostics, marketing, and biotech. He started his business career at Johnson & Johnson, marketing Tylenol. Rob launched his career as a naval aviator flying the Navy’s E-2C Hawkeye.